Johnson Johnson Aktie
134,02
EUR
+1,20
EUR
+0,90
%
151,83
USD
+0,16
USD
+0,11
%
nachbörslich
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele der Johnson Johnson-Aktie in
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 137,65 GBP | +37,54% |
| Bayer | 1 | 8 | 0 | 25,29 EUR | +33,11% |
| Beiersdorf AG | 8 | 1 | 2 | 145,80 EUR | +26,62% |
| BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +36,42% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Douglas | 3 | 1 | 0 | 18,12 EUR | +93,59% |
| Fresenius Medical Care (FMC) St. | 3 | 5 | 2 | 45,17 EUR | +7,75% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 45,50 EUR | +23,98% |
| GSK PLC Registered Shs | 2 | 5 | 1 | 16,53 GBP | +27,74% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 180,57 EUR | +54,73% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +156,98% |
| MorphoSys | 0 | 1 | 0 | 68,00 EUR | - |
| Nestlé SA (Nestle) | 3 | 7 | 1 | 85,80 CHF | +0,96% |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +15,87% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 30,40 USD | +38,75% |
| Procter & Gamble Co. | 0 | 0 | 0 | - | - |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 115,50 EUR | +28,94% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Unilever plc | 6 | 1 | 3 | 48,34 GBP | - |
| Valneva | 0 | 0 | 0 | - | - |